Mayo Clinic
Rochester, Minnesota, 55905, United States
Location status: Recruiting
NCT Number: NCT07225803
The purpose of this research is to better understand constipation and improve biofeedback treatments.
Interested in participating?
Request Info18 year–80 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
During anorectal biofeedback therapy, subjects are coached to improve abnormal patterns while observing activity recorded by manometry and/or surface EMG (electromyography) on a computer monitor while seated on a chair or a commode.
Subjects will engage in inspiratory muscle training (IMT) that is tailored to the baseline performance of the individual.
Time frame: Baseline, through study completion, an average of 16 weeks
Rectoanal gradient during evacuation is the pressure difference between the rectum and the anal canal during simulated evacuation, measured in millimeters of mercury (mmHg).
Time frame: Baseline, through study completion, an average of 16 weeks
Rectal pressure during evacuation is the difference in rectal pressure during - before evacuation. Results are measured in millimeters of mercury (mmHg).
Time frame: Baseline, through study completion, an average of 16 weeks
Rectal balloon expulsion directly assesses evacuation. Patients will be asked to expel a rectal balloon inflated up to 50 ml of water. The time required to expel the balloon will be measured and reported in seconds.
Time frame: Baseline, through study completion, an average of 16 weeks
Rectal emptying will be assessed via fecoflowmetry by measuring the time required to defecate (seconds) artificial stool from the rectum
Time frame: Baseline, through study completion, an average of 16 weeks
Rectal emptying will be assessed via fecoflowmetry by measuring the amount (gm) of artificial stool from the rectum. The 2 metrics - amount and time - are integrated to measure amount (gm) evacuated per unit time (second) (gm/sec).
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
The PAC-SYM questionnaire assesses the severity of patient-reported symptoms related to constipation. The questionnaire is divided into three symptom subscales: abdominal (four items); rectal (three items); and stool (five items). Items are scored on 5-point Likert scales, with scores ranging from 0 to 4 (0 = 'symptom absent', 1 = 'mild', 2 = 'moderate', 3 = 'severe' and 4 = 'very severe'). A mean total score in the range of 0-4 is generated by dividing the total score by the number of questions completed; the lower the total score, the lower the symptom burden. Scores range from 0 to 48.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion , 12 months post completion
The PAC-QOL questionnaire is a patient-reported outcome measure to evaluate quality of life in constipated persons. The questionnaire is divided into four subscales: worries and concerns (11 items), physical discomfort (4 items), psychosocial discomfort (8 items), and satisfaction (5 items). Scale scores represent average item scores and range from 0 to 4, where higher scores represent poorer quality of life. Scores range from 0 to 112.
Time frame: Baseline
Physical Activity Rating is a questionnaire for categorizing physical activity level, which is used in the equation for the non-exercise fitness test. The Physical Activity Rating is a score value between 0 to 7. The non-exercise fitness test of VO2max, a measure of cardiovascular fitness, will be calculated using the following equation:
56.363 + 1.921 (Physical Activity Rating) - 0.381(Age) - 0.754(Body Mass Index) + 10.987(Sex: 0 for women, 1 for men)
Time frame: through study completion, an average of 16 weeks
Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST) 11-item questionnaire is a standardized tool to measure the satisfaction of an individual who is using an assistive device. It inquiries about the assistive device itself: dimensions, weight, ease of adjustment, safety, durability, ease of use, comfortability, and effectiveness; and service: service delivery, maintenance, professional services, and follow up services. Each question is answered on a Likert scale, where 1 = not satisfied at all, and 5 = very satisfied. Possible scores range from 11 to 55.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Daily number of bowel movements will be self-reported by participants via a bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Daily stool consistency will be self-reported by participants via a bowel diary by using the Bristol Stool Chart. Participants will compare stool's appearance to the 7 types and selecting the one that most closely matches. Type 1-2 indicate constipation, Type 3-4 are ideal stools as they are easier to pass, and Type 5-7 may indicate diarrhea and urgency.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
The total number of times anal digitation was required to achieve a bowel movement will be self-reported via the bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
The total number of times a participant felt a sense of incomplete evacuation after a bowel movement will be self-reported via the bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
The total number of times a participant achieves a spontaneous bowel movement will be self-reported via the bowel diary.
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Pain during bowel movements will be self-reported by participants via the bowel diary using a 4-point Likert scale (0 = None, 1 = Mild, 3 = Moderate, and 4 = Severe).
Time frame: Baseline, through study completion, an average of 16 weeks, 3 months post completion, 12 months post completion
Bowel symptoms pre and post biofeedback therapy will be assessed using a self-reported questionnaire. The survey includes Severity of constipation, satisfaction with bowel movements, satisfaction with current treatment of constipation, severity of constipation compared to baseline, adequate relief of constipation, use of laxatives, and severity of abdominal bloating and distention. Impact of constipation on 15 QOL domains.
Time frame: Baseline, through study completion, an average of 16 weeks
The Hospital Anxiety and Depression (HAD) is a self-reported 14 item questionnaire asking participants to reflect on their mood in the past week. . Each item is rated on a 4-point scale, for a total score ranging from 0-21 for each subscale. A higher score indicates higher distress.
Time frame: Baseline, through study completion, an average of 16 weeks
Forced vital capacity (FVC) is the the total volume of air exhaled with maximal effort, and is measured using a spirometer (reported in liters).
Time frame: Baseline, through study completion, an average of 16 weeks
Forced expiratory volume (FEV) is the total volume of air exhaled with maximal effort, and is measured using a spirometer (reported in liters).
Time frame: Baseline, through study completion, an average of 16 weeks
Forced expiratory time (FET) is the time taken to exhale the greatest volume of air from the lungs as possible and is measured using a spirometer (reported in seconds).
Time frame: Baseline, through study completion, an average of 16 weeks
Peak inspiratory flow (PIF) is the maximum volume and rate of air that can be forcefully inhaled out of the lungs, and is measured using a spirometer (reported in liters per second (L/sec)).
Time frame: Baseline, through study completion, an average of 16 weeks
Peak expiratory flow (PEF) is the maximum volume and rate of air that can be forcefully exhaled out of the lungs and is measured using a spirometer (reported in in liters per second (L/sec)).
Time frame: Baseline, through study completion, an average of 16 weeks
The total volume of air exhaled with maximal effort / The volume of air exhaled with maximum effort in the first second (reported as percentage).
Time frame: Baseline, through study completion, an average of 16 weeks
The average flow from the point at which 25% of the forced vital capacity has been exhaled to the point at which 75% of the forced vital capacity has been exhaled. A reduced forced expiratory flow 25-75% is a marker of small airway obstruction.
Time frame: Baseline, through study completion, an average of 16 weeks
The flow rate at the point at which 50% point of the forced vital capacity has been exhaled, and is a marker of small airway obstruction.
Time frame: Baseline, through study completion, an average of 16 weeks
Forced inspiratory vital capacity is the maximum volume of air that can be inhaled after a full expiration (reported in liters).
Time frame: Baseline, through study completion, an average of 16 weeks
Peak inspiratory pressure is the peak pressure during forceful inspiration against an occluded airway (Mueller maneuver), reported in liters per minute (L/min)
Time frame: Baseline, through study completion, an average of 16 weeks
Peak expiratory pressure is the peak pressure during forceful expiration against an occluded airway (Valsalva maneuver), reported in liters per minute (L/min)
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05771597
Digestive System Diseases, Dyssynergic Defecation
Augusta, Georgia, United States
View Trial DetailsNCT07683390
Dyssynergic Defecation, Impaired Rectal Evacuation
Yuzhong, Chongqing Municipality, China
View Trial DetailsNCT07545772
Colonic Diseases, Colonic Diseases, Functional
Mesa, Arizona, United States
View Trial DetailsNCT07705542
Anismus, Ataxia
Hull, United Kingdom
View Trial Details